MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia

    B. Veiga, C. Silva, S. Silva, R. Saba, H. Ferraz, V. Borges (São Paulo, Brazil)

    Objective: To study Impulsive Compulsive Behaviors (ICBs) and Levodopa-Induced Dyskinesias (LIDs) in Young Onset Parkinson's disease (YOPD) patients. Background: Parkinson's disease (PD) is a neurodegenerative…
  • 2024 International Congress

    Fatigue in Parkinson’s Disease: Prevalence and Risk Factors

    C. Falup-Pecurariu, I. Murasan, D. Rusu, B. Opritoiu, L. Ungureanu, L. Irincu, I. Despa, S. Diaconu (Brasov, Romania)

    Objective: To determine the prevalence of fatigue among people with PD (PwP) in comparison to the general population and to identify fatigue associated factors. Background:…
  • 2024 International Congress

    Exploring Supervised and Real-World Mobility in People with Parkinson’s Disease with and without Nocturnal Hypokinesia

    E. Bianchini, D. Rinaldi, S. Galli, M. Alborghetti, L. de Carolis, P. Petit, P. Pacilio, T. Milane, C. Hansen, FE. Pontieri, N. Vuillerme (Rome, Italy)

    Objective: To evaluate supervised and real-world mobility in people with Parkinson’s disease (PwPD) with and without nocturnal hypokinesia (NH). Background: Mobility impairment and NH are…
  • 2024 International Congress

    The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease

    T. Abali, SN. Kibrit, Z. özdamar, İ. Köker, AV. Karacan, MK. Yekedüz, R. Yilmaz, FT. Eminoglu, MC. Akbostancı (Ankara, Turkey)

    Objective: To understand the impact of the comorbidities; namely Type 2 Diabetes Mellitus (DM) and/or cardiovascular disease (CVD) on the clinical features of Parkinson’s disease…
  • 2024 International Congress

    Subjective Sleep Quality and Pathological Sleepiness in Veterans with Parkinson’s Disease

    A. Sarwar (PEARLAND, USA)

    Objective: To determine the subjective sleep quality and its association with pathological sleepiness in Veterans with Parkinson's disease (PD). Background: Sleep quality issues and pathological…
  • 2024 International Congress

    Systematic Review and Meta-Analysis of Pesticide Exposure and the Risk of Parkinson’s Disease

    J. Cheong, ZHK. Goh, H. Frankland, S. Spearman, J. Steinmetz, A. Noyce (London, United Kingdom)

    Objective: This study aimed to investigate the association between exposure to pesticides and the risk of Parkinson’s disease (PD). Background: PD is the second most…
  • 2024 International Congress

    Profile of patients affected by movement disorders in subspecialized outpatient clinics of a tertiary hospital in Southern Brazil

    D. Teixeira-Dos-Santos, G. Magalhães Pereira, T. de Carvalho, P. Ribeiro Rigo, J. Käfer Pasin, I. Fonseca Benati, E. Drews Amorim, M. Testa-da-Silva, T. Lampert Monte, BS. de Oliveira, R. Machado Castilhos, AF. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To delineate the epidemiological and clinical characteristics of movement disorders (MD) in patients attending subspecialty clinics at a tertiary hospital in Southern Brazil. Background:…
  • 2024 International Congress

    Reliability and Validity of the English Version of the Parkinson Anxiety Scale

    J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…
  • 2024 International Congress

    Quality Improvement of Careflow Referrals to Parkinson’s Disease Nurse Specialist (PDNS) Service at East Kent Hospitals University Foundation Trust (EKHUFT)

    N. Natarajan, H. Hassan, M. Ahmed, N. Patel, K. Lauckaite (Solihull, United Kingdom)

    Objective: The aim of this study was to increase the proportion of appropriate referrals to 70% using an online banner. A secondary objective was to…
  • 2024 International Congress

    Long-term Physical Exercise on Bone Mineral Density, Balance and Gait in Older Adults with Mild to Moderate Parkinson’s Disease

    L. Leandro, T. Zotz, O. Matos, M. Olandoski, C. Moreira (Pinhais, Brazil)

    Objective: To determine the effects of a long-term exercise program on bone health, balance and gait in older adults with mild to moderate Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley